MediWound Ltd.’s $10 Million Shares Offering

Gornitzky represented Oppenheimer in the deal. MediWound Ltd., a biopharmaceutical company, executed a U.S. $10 million underwritten follow-on public offering of ordinary shares on Nasdaq. MediWound develops, manufactures and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here